(Q40586220)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11906359%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

The safety and efficacy of subcutaneous birch pollen immunotherapy - a one-year, randomised, double-blind, placebo-controlled study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11906359%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

0 references

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11906359%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

L K Poulsen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11906359%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

H H Jacobi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11906359%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

H-J Malling

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11906359%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 April 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11906359%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11906359%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11906359%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11906359%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

297-305

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11906359%20AND%20SRC:MED&resulttype=core&format=json

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. I. Efficacy estimated by a model reducing the bias of annual differences in pollen counts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

Immunotherapy with partially purified and standardized tree pollen extracts. I. Clinical results from a three-year double-blind study of patients treated with pollen extracts either of birch or combinations of alder, birch and hazel

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

Survey of fatalities from skin testing and immunotherapy 1985-1989.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

Fatalities from immunotherapy (IT) and skin testing (ST)

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

Quality of life in allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

The precision of the conjunctival provocation test

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

Ragweed immunotherapy in adult asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

Clinical guidelines: developing guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

Position paper: Immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

7 January 2021

Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity during pollen season

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

7 January 2021

Immunotherapy in children with allergic asthma: effect on bronchial hyperreactivity and pharmacotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

7 January 2021

Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. II. Side-effects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

7 January 2021

Histamine and tryptase in nasal lavage fluid following challenge with methacholine and allergen

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

7 January 2021

Sensitive glass microfibre-based histamine analysis for allergy testing in washed blood cells. Results compared with conventional leukocyte histamine release assay

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

7 January 2021

Short-term immunotherapy: a prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

7 January 2021

Immunotherapy with Alpare in patients with respiratory allergy to Parietaria pollen: a two year double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

7 January 2021

Immunotherapy with partially purified and standardized tree pollen extracts. II. Results of skin prick tests and nasal provocation tests from a three-year double-blind study of patients treated with pollen extracts either of birch or combinations of

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

7 January 2021

Immunotherapy with partially purified and standardized tree pollen extracts. IV. Results from long-term (6-year) follow-up

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

7 January 2021

Diagnosis and immunotherapy of mould allergy. VI. IgE-mediated parameters during a one-year placebo-controlled study of immunotherapy with Cladosporium

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

7 January 2021

Evaluation of immunotherapy-induced changes in specific IgE, IgG and IgG subclasses in birch pollen allergic patients by means of immunoblotting

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

7 January 2021

Allergic rhinitis to ragweed pollen. I. Reassessment of the effects of immunotherapy on cellular and humoral responses

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1O3532.X

7 January 2021